Sana Intidhar Labidi-Galy

12PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 10, 2026
Profiling tumor immune microenvironment of epithelial ovarian carcinoma.

|Sep 02, 2026
High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.

|Jan 06, 2026
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.

Hiba Mechahougui, Léna Royston, Catia Vieira Gomes

|Jul 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.

Olivia Le Saux, Maude Ardin, Justine Berthet

|May 24, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.

Diego Dibitetto, Martin Liptay, Francesca Vivalda

|Dec 19, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.

Judith Balmaña, Peter A Fasching, Fergus J Couch

Pageof 2

Frequent Collaborators

1 joint publications

Judith Balmaña

1 joint publications

Peter A Fasching

1 joint publications

Fergus J Couch

1 joint publications

Suzette Delaloge